Ninewells Hospital and Medical School
Dundee, DD1 9SY, United Kingdom
NCT Number: NCT01858246
The Bonebridge is a new bone conducting implantable hearing aid. The investigators plan to randomize patients to receive either the Bonebridge or a conventional bone conducting hearing device. The investigators will then compare the surgical and audiological outcomes of the two groups.
Looking for future studies?
Notify Me16 year–85 year
All sexes
Interventional
Not applicable
Dundee, DD1 9SY, United Kingdom
The new Bonebridge fully implanted, except for an external sound processor. It does not have any percutaneous parts like the Bone Anchored Hearing Aid. The investigators believe that this may improve wound healing and reduce problems with wound infection and skin overgrowth seen in Bone Anchored Hearing Aids.
There may also be audiological improvements by the use of the Bonebridge as the physical separation of the vibrating part from the sound processor should reduce feedback. The company also claims other audiological improvements in the Bonebridge.
The investigators wish to demonstrate whether this is actually the case by performing a study directly comparing the outcomes of the two groups.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Up to 1 year post-operatively
We will record and compare the standard speech audiometry results at a specific sound level in order to make a direct comparison of devices
Time frame: Up to 1 year after implantation
The speech audiogram will also be carried out in noise to demonstrate whether one device gives an appreciable advantage over another with respect to understanding in noise compared to silence.
Time frame: Up to 1 year following implantation
Patients will be asked to complete the Glasgow Benefit Inventory (GBI) and Hearing Device Satisfaction Scale (HDSS) questionnaires
Time frame: Up to 3 months
The time (measured in days) will be recorded from the date of implantation to the date of its switch-on.
Time frame: 1 year from implantation
Time frame: Up to 3 months from implantation
Measured in days, as judged subjectively by ENT medical and nursing staff
Ninewells Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03766152
Bone Conduction Deafness, Ear Diseases
Vienna, Austria
View Trial DetailsNCT06634784
Children Under 5 Years, Ear Diseases
Hanover, Lower Saxony, Germany
View Trial DetailsNCT06338670
Ear Diseases, Hearing Disorders
Melbourne, Victoria, Australia
View Trial DetailsNCT07156461
Bone Conduction, Ear Diseases
Denver, Colorado, United States
View Trial Details